Washington, DC Metropolitan Area Drug Study (DC*MADS) Series
DC*MADS was undertaken to assess
the full extent of the drug problem in one metropolitan area. The
study was comprised of 16 separate studies that focused on different
sub-groups, many of which are typically not included or are
underrepresented in household surveys. This data collection includes
three of these component studies:
Study of Household and
Non-household Populations examined the prevalence of tobacco, alcohol,
and drug use among members of household and non-household populations
aged 12 and older. The study also examined the characteristics of three
drug-abusing sub-groups: crack-cocaine, heroin, and needle users. The
household sample was drawn from the 1991 NHSDA; the
non-household sample was drawn from the DC*MADS Institutionalized and
Homeless and Transient Population Studies. Data include demographics,
needle use, needle sharing, and use of tobacco, alcohol, cocaine,
crack, inhalants, marijuana, hallucinogens, heroin, sedatives,
stimulants, and psychotherapeutics (non-medical use).
Homeless and Transient Population Study examined the prevalence of illicit drug, alcohol, and tobacco use among members of the homeless and transient population aged 12 and older in the Washington, DC, Metropolitan Statistical Area (DC MSA). The sample frame included respondents from shelters, soup kitchens and food banks, major cluster encampments, and literally homeless people. Information collected includes data on previous living arrangements, tobacco, drug, and alcohol use, consequences of use, treatment history, illegal behavior and arrest, physical and mental health, pregnancy, insurance, employment and finances, and demographics.
Drug Use Among Women Delivering Livebirths in D.C. Hospitals was designed to examine the nature and extent of drug use among women delivering live births in eight Washington, DC, hospitals participating in the study. Information collected includes data on tobacco, alcohol, and drug use, patterns of use, respondent's general experiences with drug use, including perceptions of the risks and consequences of use, treatment experiences, pregnancy history, and maternal and infant characteristics and outcomes.
DC*MADS was sponsored by the
National Institute on Drug Abuse.